Amanda R Brummel
Overview
Explore the profile of Amanda R Brummel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zagel A, Brummel A, Chacon M, ODonnell R, Styles E, Peacock J
J Public Health Manag Pract
. 2024 Jul;
30:S141-S151.
PMID: 39041750
Objective: Evaluate a cardiovascular care intervention intended to increase access to comprehensive medication management (CMM) pharmacy care and improve vascular health goals among socially disadvantaged patients. Design: Retrospective electronic health...
2.
Zagel A, Rhodes A, Nowak J, Brummel A
Innov Pharm
. 2023 Jan;
13(2).
PMID: 36654715
: Uncontrolled hypertension is serious and may lead to severe cardiovascular events and death. To better educate and empower patients to meet their blood pressure (BP) management goals, a large,...
3.
Pestka D, Paterson N, Brummel A, Norman J, White K
Am J Health Syst Pharm
. 2022 Apr;
79(15):1255-1265.
PMID: 35390120
Purpose: How to effectively integrate pharmacists into team-based models of care to maximize the benefit they bring to patients and care teams, especially during times of primary care transformation (PCT),...
4.
Pestka D, Brummel A, Wong M, Rajpurohit A, Elert B, Farley J
J Am Coll Clin Pharm
. 2021 Nov;
4(11):1410-1419.
PMID: 34805778
Introduction: As care teams adopt team-based models of care, it is important to examine the reach of interdisciplinary services, such as pharmacists providing comprehensive medication management (CMM). This study examined...
5.
Brummel A, Sorensen T
J Manag Care Spec Pharm
. 2020 Aug;
26(9):1067-1070.
PMID: 32857660
No funding supported the writing of this commentary. Brummel has consulted, presented, or was engaged in an advisory board for UCB, Boerhinger Ingelheim, Pfizer, and Lilly. Sorenson has nothing to...
6.
Oliveira D, Brummel A, Miller D
J Manag Care Spec Pharm
. 2020 Aug;
26(9):1057-1066.
PMID: 32857651
Background: Medication therapy management (MTM) was officially recognized by the federal government in the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, which requires Medicare Part D plans that...
7.
Westberg S, Yarbrough A, Weinhandl E, Adam T, Brummel A, Reidt S, et al.
Ann Pharmacother
. 2018 Jun;
52(12):1195-1203.
PMID: 29888615
Background: Improved understanding of how drug therapy problems (DTPs) contribute to rehospitalization is needed. Objective: The primary objectives were to assess the association of DTP likelihood of harm (LoH) severity...
8.
Sorensen T, Pestka D, Brummel A, Rehrauer D, Ekstrand M
J Manag Care Spec Pharm
. 2016 Apr;
22(5):598-604.
PMID: 27123920
Disclosures: No outside funding supported this research. Brummel provides consulting services to other health systems; has received grants from Sanofi and speaking fees from AMCP, APhA, and ASHP; and is...
9.
Soliman A, Carlson A, MacLehose R, Brummel A, Schommer J
Clin Ther
. 2013 Apr;
35(4):534-40.
PMID: 23541131
Background: Patient characteristics associated with a higher exposure to medication therapy management (MTM) and the relationship between frequency of MTM visits and meeting clinically defined goals of therapy have not...
10.
Brummel A, Soliman A, Carlson A, Oliveira D
Popul Health Manag
. 2012 Nov;
16(1):28-34.
PMID: 23113628
Pharmacists play an integral role in influencing resolution of drug-related problems. This study examines the relationship between a pharmacist-led and delivered medication therapy management (MTM) program and achievement of Optimal...